
Director, Clinical AI Research & Evaluation
AstraZeneca
Summary
AstraZeneca is building an AI capability for Clinical Development that will change how trials are designed, conducted, monitored, and analyzed. We are hiring a Director, Clinical AI Research & Evaluation to lead the scientific foundation that makes clinical AI systems trustworthy, measurable, and ready to scale into regulated practice. The role sits in the Clinical AI Applied Science & Translation team, based in Boston, MA.
Job description
Role Overview
AstraZeneca is building an AI capability for Clinical Development that will change how trials are designed, conducted, monitored, and analyzed. We are hiring a Director, Clinical AI Research & Evaluation to lead the scientific foundation that makes clinical AI systems trustworthy, measurable, and ready to scale into regulated practice. The role sits in the Clinical AI Applied Science & Translation team, based in Boston, MA.
You will set the research agenda for how clinical AI systems are evaluated, how human professionals interact with AI in clinical workflows, and what evidence standards must exist before a system can be trusted at scale. This is a research leadership role with delivery accountability. You will define the methodology as we practice it, while remaining close enough to the work to credibly challenge it. You will direct a team of scientists and engineers, partner with product owners and Engineering, and establish evaluation and human-factors practices that extend across the Clinical Operations and Development AI portfolio.
Accountabilities
Research Leadership
- Define and own the scientific methodology for evaluating clinical AI systems: evaluation harnesses, benchmark construction, failure mode taxonomy, red-team protocols, and monitoring strategies across the system lifecycle.
- Build a structured catalog of ways the system can fail clinically and run structured testing before any deployment.
- Advance methods for evaluation in clinically complex conditions such as noisy or delayed ground truth, expert disagreement, multi-step agentic workflows, human in-the-loop performance, and automation bias or where simple metrics fail.
- Develop human factors and workflow-integration methods beyond usability testing: how AI output shapes human judgment, what oversight mechanisms are effective, how clinical professionals calibrate trust in AI-assisted work, and what human review effectively ensure patient safety.
- Publish and communicate findings externally where appropriate to build AstraZeneca’s scientific credibility and attract research talent.
Applied Delivery
- Design and implement evaluation frameworks that determine when a system is ready to move from prototype to controlled pilot, from pilot to deployment, and from non-GxP to regulated use.
- Participating in defining human review requirements for user facing AI outputs: what requires sign-off before action, what can be surfaced directly, and how oversight should be structured in the validation plan.
- Build evaluation assets such as test sets, simulation environments, scoring rubrics, regression suites, and analysis pipelines, some or all of which are reusable across
- Lead hands-on failure analysis: fabrications/falsifications, unsupported claims, data leakage, subgroup performance, and unsafe workflow behavior.
- Be part of a team of scientists and engineers focused on evaluation, human factors, and responsible deployment.
Cross-Functional Governance
- Work with Quality, Regulatory, Privacy, Security, and R&D IT to ensure evaluation of evidence meets GxP, data integrity, and inspection-readiness requirements from the outset.
- Advise product owners and leadership on evidence-based go or no-go decisions; communicate residual risk clearly.
- Create reusable evaluation standards and clinical AI governance practices that can be adopted across AISI’s Clinical Development portfolio and contribute to broader industry standards.
- Represent the team’s scientific position in external forums, standards bodies, and regulatory engagements where relevant.
Requirements
- PhD in Machine Learning, Computer Science, Human-Computer Interaction, Statistics, Biomedical Informatics, or a related quantitative discipline; or an MD or equivalent experience with a research record that demonstrates comparable rigor.
- 8 or more years of post-PhD (or equivalent) experience in AI/ML research, evaluation science, or human factors in healthcare, life sciences, clinical research, or another safety-critical domain.
- Deep expertise in evaluation methodology for AI/ML systems: experimental design, statistical inference, uncertainty quantification, measurement reliability, and evaluation of LLM-based or multi-step agentic workflows.
- Demonstrated research leadership: ability to set a scientific agenda, direct a team, produce research outputs, and translate principled methodology into practical, shipping systems.
- Current, hands-on coding ability in Python and SQL, including evaluation pipelines, data analysis, statistical testing, and version-controlled collaborative development.
- Strong grounding in human-computer interaction or human factors and its application to AI-assisted decision-making in high-stakes environments.
- Excellent communication skills across technical, clinical, quality, regulatory, and executive audiences; ability to represent uncertainty and residual risk without overstating or obscuring.
- Demonstrated ability to lead cross-functional work through influence, including go or no-go recommendations under ambiguity.
- Experience with LLM evaluation platforms, LLMOps/MLOps & observability for deployed AI systems.
Benefits
- 401(k) retirement programs
- Paid time off
- Holidays
- Health, dental & vision
- Short-term incentive bonuses
- Equity-based awards
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.